The human T-cell leukemia/lymphotropic virus type 1 p12 protein binds the interleukin-2 receptor β and γc chains and affects their expression on the cell surface

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3599-3605

  Mulloy, James C ^a   Crowley, Richard W ^a   Fullen, Jake ^a   Leonard, Warren J ^b   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Natl Heart Lung/Blood Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROTON PUMP;

ARTICLE; BETA CHAIN; BINDING AFFINITY; CELL PROLIFERATION; CELL SURFACE; CELL TRANSFORMATION; HUMAN T CELL LEUKEMIA VIRUS 1; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION; VIRUS EXPRESSION; VIRUS TRANSFORMATION;

GOLGI APPARATUS; HELA CELLS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE PROTEINS;

EID: 0029936174     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Arya, S. K., F. Wong-Staal, and R. C. Gallo. 1984. T-ccll growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science 223:1086-1087.
2. Berneman, Z. N., R. B. Gartenhaus, M. S. Reitz, Jr., W. A. Blattner, A. Manns, B. Hanchard, O. Ikehara, R. C. Gallo, and M. E. Klotman. 1992. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. USA S9:3005-3009.
3. Blattner, W. A. 1990. Epidemiology of HTLV-1 and associated diseases, p. 251. Raven Press, New York.
4. Broder, S. 1986. T cell proliferation and ablation. A biologic spectrum of abnormalities induced by the human T cell lymphotropic virus group. Prog. Allergy 37:224-243.
5. Cereseto, A., F. Diella, J. C. Mulloy, A. Cara, R. Grassmann, G. Franchini, and M. E. Klotman. Unpublished data.
6. Cesarman, E., A. Chadburn, G. Inghirami, G. Gaidano, and D. M. Knowles. 1992. Structural and functional analysis of oncogencs and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 80:3205-3216.
7. Cohen, B. D., D. J. Goldstein, L. Rutledge, W. C. Vass, D. R. Lowy, R. Schlegel, and J. T. Schiller. 1993. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J. Virol. 67:5303-5311.
8. Cross, S. L., M. B. Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, and W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor a chain promoter: activation of a non-functional promoter by the transactivator gene of HTLV-1. Cell 49:47-56.
9. Danial, N. N., A. Pernis, and P. B. Rothman. 1995 Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875-1877.
10. Finhow, M. E., E. E. Eliopoulos, P. J. Jackson, J. N. Keen, L. Meagher, P. Thompson, P. Jones, and J. B. C. Findlay. 1992. Structure of a 16 kDa integral membrane protein that has identity to the putative proton channel of the vacuolar H+-ATPase. Protein Eng. 5:7-15.
11. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
12. - ATPase. J. Virol. 67:7701-7704.
13. Fujii, M., P. Sassone-Corsi, and I. M. Verraa. 1988. c-fos promoter transactivation by the Taxi protein of human T-ccll leukemia virus type I. Proc. Natl. Acad. Sci. USA 85:8526-8530.
14. Gallo, R. C. 1986. The first human retrovirus. Sci. Am. 255:88-98.
15. Gessain, A., F. Barin, J.-C. Vernant, O. Gout, L. Maurs, A. Calendar, and G. de The. 1985. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet ii:407-410.
16. Goldstein, D. J., T. Andresson, J. J. Sparkowski, and R. Schlegel. 1992. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J. 11:4851-4859.
17. Goldstein, D. J., M. E. Finbow, T. Andresson, P. McLean, K. Smith, V. Bubb, and R. Schlegel. 1991. The bovine papillomavirus E5 oncoprotein binds to the 16 kilodalton component of vacuolar H + -ATPase. Nature (London) 352:347-349.
18. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Adhieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Gin. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-968.
19. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-460.
20. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. Kinushita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
21. Inoue, J., M. Seiki, T. Taniguchi, S. Tsoro, and M. Yoshida. 1986. Induction of interleukin 2 receptor gene expression by p40 encoded by human T-cell leukemia virus type I. EMBO J. 5:2883-2888.
22. Kanamori, H., N. Suzuki, H. Siomi, T. Nosaka, A. Sato, H. Sabe, M. Hatanaka, and T. Honjo. 1990. HTLV-1 p27 rex stabilizes human interleukin 2 receptor a chain mRNA. EMBO J. 9:4161-4166.
23. Kintura, Y., T. Takeshita, M. Kondo, N. Ishii, M. Nakamura, J. Van Snick, and K. Sugamura. 1995. Sharing of the 1L-2 receptor γ chain with the functional IL-9 receptor complex. Int. Immunol. 7:115-120.
24. Koga, Y., N. Oh-Hori, H. Sato, N. Yamamoto, G. Kimura, and K. Nomoto. 1989, Absence of transcription of Ick (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I transformed T cell lines. J. Immunol. 142:4493-4499.
25. Kondo, M., T. Takeshita, M. Higuchi, M. Nakamura, T. Sudo, S. Nishikawa, and K. Sugamura. 1994. Functional participation of the 1L-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453-1454.
26. Kondo, M., T. Takeshita, N. Ishii, M. Nakamura, S. Watanabe, K. Aral, and K. Sugamura. 1993. Sharing of the interleukin 2 (IL-2) receptor Y chain between receptors for IL-2 and IL-4. Science 262:1874-1877.
27. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 67:2360-2366.
28. Koralnik, I. J., A. Gessain, M. E. Klotman, A. LoMonico, Z. N. Berneman, and G. Franchini. 1992. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type 1. Proc. Natl. Acad. Sci. USA 89:8813-8817.
29. c. Immunol. Rev. 61:138-164.
30. Markham, P. D., S. Z. Salahuddin, V. S. Kalyanaraman, M. Popovic, P. Sarin, and R. C. Gallo. 1983. Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). Int. J. Cancer 31:413-420.
31. Maruyama, M., H. Shihaya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J. Inoiie, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 automne loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 48:343-350.
32. Migone, T.-S., J.-X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-L Science 269:79-81.
33. Mills, G., N. Arima, C. May, M. Hill, R. Schmandt, J. Li, N. G. Miyaraoto, and W. C. Greene. 1992. Neither the lck nor the fyn kinases are obligatory for IL-2 mediated signal transduction in HTLV-I-infected human T-cclls. Int. Immunol. 4:1233-1243.
34. Minami, Y., and T. Taniguchi. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5-8.
35. Miyoshi, I., I. Kuhonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, and Y. Hinuma. 1981. Type C virus particles in a cord T cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature (London) 294:770-771.
36. tax protein in the human T-cell line, Jurkat. J. Virol. 63:3220-3226.
37. Nakamuni, Y., S. M. Russell, S. A. Mess, M. Friedmann, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of the interleukin-2 receptor β and γ chain cytoplasmic domains is required for signaling. Nature (London) 369:330-333.
38. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature (London) 369:333-336.
39. Nilson, L. A., and D. DiMaio. 1993. Platelet-derived growth factor receptor can mediate tumorigcnic transformation by the bovine papillomavirus E5 protein. Mol. Cell. Biol. 13:4137-4145.
40. Noguchi, M., Y. Nakamura, S. M. Russell, S. F. Ziegler, M. Tsang, X. Cao, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science 262:1877-1880.
41. Noguchi, M., H. Yi, H. M. Rosenblatt, A. H. Fillpovich, S. Adelstein, W. S. Modi, O. W. McBride, and W. J. Leonard. 1993. Interleukin-2 receptor 7 chain mutation results in x-linked severe combined immunodeficiency in humans. Cell 73:147-157.
42. Ohashi, T., M. Masuda, and S. K. Ruscetti. 1995. Induction of sequencespecific DNA-binding factors by crythropoietin and the spleen focus-forming virus. Blood 84:1454-1462.
43. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitini, and A. Igala. 1986. HTLV-I-associated myelopathy, a new clinical entity. Lancet 1:1031-1032. (Letter.)
44. Petti, L., and D. DiMaio. 1992. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA 89:6736-6740.
45. Petti, L., L. A. Nilson, and D. DiMaio. 1991. Activation of the platelet derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10:845-855.
46. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and K. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-ccll lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
47. Popovk, M., G. Lange-Wantzin, P. S. Sarin, D. Mann, and R. C. Gallo. 1983. Transformation of human umbilical cord blood T-cell by human T-cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA 80:5402-5406.
48. Reid, R. L., P. F. Lindholm, A. Mireskandari, J. Dittmer, and J. N. Brady. 1993. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 8:3029-3036.
49. Rodgers-Johnson, P., D. C. Gajdusek, O. S. Morgan, V. Zaninavic, P. S. Sarin, and D. S. Graham. 1985. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet ii:1247-1249. (Letter.)
50. Russell, S. M., A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Friedmann, A. Miyajima, R. K. Puri, W. E. Paul, and W. J. Leonard. 1993. Interleukin-2 receptor 7 chain: a functional component of the interleukin-4 receptor. Science 262:1880-1882.
51. Schlegel, R., M. Wade-Glass, M. S. Rabson, and Y. Chung Yang. 1986. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science 233:233-236.
52. Siekevitz, M., M. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2-receptor (tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus, type 1. Proc. Natl. Acad. Sci. USA 84:5389-5393.
53. Suzuki, J., T. Takeshita, K. Ohbo, H. Asao, K. Tada, and K. Sugamura. 1989. IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody. Int. Immunol. 1:373-377.
54. Tsudo, M., F. Kitamura, and M. Miyasaka. 1989. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA 86:1982-1986.
55. Voss, S. D., P. M. Sondel, and R. J. Robb. 1992. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R γ chain with the IL-2R β chain in functional intermediate-affinity IL-2R. J. Exp. Med. 176:531-541.
56. Waldmann, T. A., J. D. White, C. K. Goldman, L. Top, A. Grant, R. Bamford, E. Roessler, I. D. Hurak, S. Zaknoen, and C. Kasten-Sportes. 1993. The interleukin 2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus I-induced adult T-cell leukemia. Blood 82:1701-1712.
57. Watowich, S., A. Yoshimura, G. D. Longmore, D. J. Hilton, Y. Yoshimura, and H. F. Lodish. 1992. Homodimerization and constitutive activation of the erylhropoietin receptor. Proc. Natl. Acad. Sci. USA 89:2140-2144.
58. White, K. N., T. Nosaka, H. Kanamori, M. Hatanaka, and T. Honjo. 1991. Nucleolar localization signal of the HTLV-I protein p27 rex is important for stabilization of IL-2 receptor alpha subunit mRNA by p27 rex. Biochem. Biophys. Res. Commun. 175:98-103.
59. Xu, X., S.-H. Kang, O. Heidenrekh, O. Michelle, J. J. O'Shea, and M. I. Nerenberg. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) Tax protein or virus-transformed cells. J. Clin. Invest. 96:1548-1555.
60. Yamaguchi, K., and K. Takalsuki. 1993. Adult T-cell leukaemia-lymphoma. Baillière's Clin. Haematol. 6:899-915.
61. Yamamoto, N., M. Okada, Y. Koyanagi, M. Kannagi, and Y. Hinuma. 1982. Transformation of human leukocytes by co-cultivation with an adult T cell leukemia virus producer cell line. Science 217:737-739.
62. lyn, in hematopoictic cells and association with production of human T-cell lymphotropic virus type 1. Proc. Natl. Acad. Sci. USA 86:6538-6542.
63. Yoshimura, A., A. D. D'Andrea, and H. F. Lodish. 1990. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc. Natl. Acad. Sci. USA 87:4139-4143.
64. Youssouflan, H., G. Longmore, D. Neumann, A. Yoshimura, and H. F. Lodish. 1993. Structure, function, and activation of the erythropoietin receptor. Blood 81:2223-2236.
65. Zamhetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.